Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Adial Pharmaceuticals, Inc. (ADIL) had Income from Continuous Operations of $0.00M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-51.99M |
|
-- |
|
-- |
|
$52.02M |
|
$-52.02M |
|
$0.04M |
|
$-51.99M |
|
$-51.99M |
|
$0.00M |
|
|
Income from Continuous Operations |
$0.00M |
$0.00M |
|
$0.00M |
|
$-52.02M |
|
$-52.02M |
|
4.62M |
|
4.62M |
|
$-11.25 |
|
$-11.25 |
|
| Balance Sheet Financials | |
$28.84M |
|
-- |
|
$0.24M |
|
$29.09M |
|
$5.12M |
|
-- |
|
$62.34M |
|
$67.47M |
|
$-38.38M |
|
$-38.38M |
|
$-38.38M |
|
2.63M |
|
| Cash Flow Statement Financials | |
$-7.97M |
|
$5.28M |
|
$25.52M |
|
$5.88M |
|
$28.71M |
|
$22.83M |
|
$0.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.00% |
|
0.00% |
|
0.00% |
|
0.00% |
|
$-14.61 |
|
$-1.73 |
|
$-1.73 |
|